These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29701928)

  • 41. Developments in impulse control behaviours of Parkinson's disease.
    Zurowski M; O'Brien JD
    Curr Opin Neurol; 2015 Aug; 28(4):387-92. PubMed ID: 26110803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impulse Control Disorders in Parkinson's Disease are Associated with Alterations in Reward-Related Cortical Oscillations.
    Carriere N; Bourriez JL; Delval A; Derambure P; Defebvre L; Dujardin K
    J Parkinsons Dis; 2016 Jun; 6(3):651-66. PubMed ID: 27372215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recurrent Impulse Control Disorder Associated with Rasagiline Treatment of Parkinson's Disease.
    Levy A; Lang AE
    Can J Neurol Sci; 2017 Jul; 44(4):447-448. PubMed ID: 28767029
    [No Abstract]   [Full Text] [Related]  

  • 44. Impulsive-compulsive behaviours in Parkinson's disease--prevention is better than cure.
    Ryan SA; O'Sullivan SS
    Ir Med J; 2013 Jun; 106(6):162. PubMed ID: 23909147
    [No Abstract]   [Full Text] [Related]  

  • 45. Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.
    Seeman P
    Synapse; 2015 Apr; 69(4):183-9. PubMed ID: 25645960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Creativity related to dopaminergic treatment: A multicenter study.
    Garcia-Ruiz PJ; Martinez Castrillo JC; Desojo LV
    Parkinsonism Relat Disord; 2019 Jun; 63():169-173. PubMed ID: 30824283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypersexuality due to dopaminergic drugs.
    Prescrire Int; 2005 Dec; 14(80):224. PubMed ID: 16400746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between REM sleep behaviour disorder and impulse control disorder in patients with Parkinson's disease.
    Bellosta Diago E; Lopez Del Val LJ; Santos Lasaosa S; López Garcia E; Viloria Alebesque A
    Neurologia; 2017 Oct; 32(8):494-499. PubMed ID: 27087472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Augmentation and impulsivity in restless legs syndrome patients: A complex interaction.
    O'Sullivan SS; Poyares D
    Neurology; 2016 Jul; 87(1):15-6. PubMed ID: 27261094
    [No Abstract]   [Full Text] [Related]  

  • 50. Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease.
    Kimber TE; Thompson PD; Kiley MA
    J Clin Neurosci; 2008 Feb; 15(2):205-8. PubMed ID: 18068992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impulsive and compulsive behaviors in Parkinson's disease.
    Evans AH; Strafella AP; Weintraub D; Stacy M
    Mov Disord; 2009 Aug; 24(11):1561-70. PubMed ID: 19526584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New medication recommended for Parkinson's disease.
    Levenson D
    Rep Med Guidel Outcomes Res; 2001 Jun; 12(13):7-9. PubMed ID: 12182172
    [No Abstract]   [Full Text] [Related]  

  • 53. Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel.
    Solla P; Cannas A; Marrosu MG; Marrosu F
    Parkinsonism Relat Disord; 2015 Nov; 21(11):1383-4. PubMed ID: 26453388
    [No Abstract]   [Full Text] [Related]  

  • 54. The high prevalence of impulse control behaviors in patients with early-onset Parkinson's disease: A cross-sectional multicenter study.
    Vela L; Martínez Castrillo JC; García Ruiz P; Gasca-Salas C; Macías Macías Y; Pérez Fernández E; Ybot I; Lopez Valdés E; Kurtis MM; Posada Rodriguez IJ; Mata M; Ruiz Huete C; Eimil M; Borrue C; Del Val J; López-Manzanares L; Rojo Sebastian A; Marasescu R
    J Neurol Sci; 2016 Sep; 368():150-4. PubMed ID: 27538621
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Man With Persistent Dopamine Agonist Withdrawal Syndrome After 7 Years Being Off Dopamine Agonists.
    Huynh NT; Sid-Otmane L; Panisset M; Huot P
    Can J Neurol Sci; 2016 Nov; 43(6):859-860. PubMed ID: 26842385
    [No Abstract]   [Full Text] [Related]  

  • 56. Increased frequency and range of sexual behavior in a patient with Parkinson's disease after use of pramipexole: a case report.
    Munhoz RP; Fabiani G; Becker N; Teive HAG
    J Sex Med; 2009 Apr; 6(4):1177-1180. PubMed ID: 18466265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of Pathological Gambling and Impulse Control Disorders With Dopamine Agonists: A Retrospective Cohort Study.
    Sodhi M; Etminan M; Carleton B; Samii A
    J Clin Psychopharmacol; 2019; 39(6):675-676. PubMed ID: 31688453
    [No Abstract]   [Full Text] [Related]  

  • 58. My husband was recently diagnosed with Parkinson's disease. His illness is now under control but he has developed a dangerous gambling habit. Is there a connection between Parkinson's disease and gambling?
    Miller MC
    Harv Ment Health Lett; 2008 Oct; 25(4):8. PubMed ID: 19024767
    [No Abstract]   [Full Text] [Related]  

  • 59. A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists.
    Rizos A; Sauerbier A; Antonini A; Weintraub D; Martinez-Martin P; Kessel B; Henriksen T; Falup-Pecurariu C; Silverdale M; Durner G; Røkenes Karlsen K; Grilo M; Odin P; Chaudhuri KR;
    Eur J Neurol; 2016 Aug; 23(8):1255-61. PubMed ID: 27170229
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of impulse control disorders in Parkinson's disease: Practical considerations and future directions.
    Ramirez-Zamora A; Gee L; Boyd J; Biller J
    Expert Rev Neurother; 2016; 16(4):389-99. PubMed ID: 26923084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.